APA (7th ed.) Citation

M, Y. S., AR, T., A, D., D, N., KK, C., YK, V., . . . EM, S. (2025). Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction. Blood advances, 9(13), 3213. https://doi.org/10.1182/bloodadvances.2024015324

Chicago Style (17th ed.) Citation

M, Yisraeli Salman, et al. "Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy Induction." Blood Advances 9, no. 13 (2025): 3213. https://doi.org/10.1182/bloodadvances.2024015324.

MLA (9th ed.) Citation

M, Yisraeli Salman, et al. "Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy Induction." Blood Advances, vol. 9, no. 13, 2025, p. 3213, https://doi.org/10.1182/bloodadvances.2024015324.